Tetrabutylammonium Fluoride → (S)-2-hydroxy-3-((S)-1-methoxypropan-2-yloxy)-N-(5-methylpyrazin-2-yl)propanamide
反応式
[F-].C([N+](CCCC)(CCCC)CCCC)CCC.[Si]([O:26][C@@H:27]([CH2:38][O:39][C@@H:40]([CH3:44])[CH2:41][O:42][CH3:43])[C:28]([NH:30][C:31]1[CH:36]=[N:35][C:34]([CH3:37])=[CH:33][N:32]=1)=[O:29])(C(C)(C)C)(C)C>C1COCC1>[OH:26][C@@H:27]([CH2:38][O:39][C@@H:40]([CH3:44])[CH2:41][O:42][CH3:43])[C:28]([NH:30][C:31]1[CH:36]=[N:35][C:34]([CH3:37])=[CH:33][N:32]=1)=[O:29]参加物
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
Tetrabutylammonium fluoride (1M in THF) (1199 μl, 1.20 mmol) was added to (S)-2-(tert-butyldimethylsilyloxy)-3-((S)-1-methoxypropan-2-yloxy)-N-(5-methylpyrazin-2-yl)propanamide (Intermediate Y2) (230 mg, 0.60 mmol) in THF (3.0 mL) at 20° C. The resulting solution was stirred at room temperature for 3 hours. The reaction mixture was concentrated and diluted with ethyl acetate (50 mL), and washed sequentially with water (25 mL) and saturated brine (10 mL). The organic layer was dried (MgSO4) and evaporated. The crude product was purified by flash silica chromatography, eluting with 100% ethyl acetate to afford the product (80 mg, 50%). 1H NMR (400 MHz, CDCl3) δ 1.16 (d, 3H), 2.53 (s, 3H), 3.34-3.45 (m, 5H), 3.66-3.81 (m, 2H), 3.97-4.03 (m, 1H), 4.30 (d, 1H), 4.34-4.39 (m, 1H), 8.13 (d, 1H), 9.30 (s, 1H), 9.41 (d, 1H); m/z (ESI+) (M+H)+=270.29; HPLC tR=0.95 min.
後処理
- concentrationThe reaction mixture was concentrated
- additiondiluted with ethyl acetate (50 mL)
- washwashed sequentially with water (25 mL) and saturated brine (10 mL)
- dry with materialThe organic layer was dried (MgSO4)
- customevaporated
- customThe crude product was purified by flash silica chromatography
- washeluting with 100% ethyl acetate
出典と根拠
- ORDレコード
- ord-f1bbf5d6566e460990bea775dc138524
- 出典データセット
- uspto-grants-2012_03
- 特許番号
- US08143263B2
反応ノート
読み込み中…